feed,title,long_url,short_url
Benzinga,ADHD Drug Developer Cingulate Plans NASDAQ Debut,https://benzinga.com/general/biotech/21/09/22887393/adhd-drug-developer-cingulate-plans-nasdaq-debut,https://j.mp/2YAa0Ib
